Katharine A. Rendle, PhD, MPH is an Associate Professor of Family Medicine & Community Health and of Epidemiology in the Perelman School of Medicine, and Director of the Penn Center for Cancer Care Innovation (PC3I). She is also the Director of Cancer Implementation Research at the Penn Implementation Science Center (PISCE), and a full member of the Abramson Cancer Center. Dr. Rendle leads a robust research program that integrates diverse quantitative and qualitative methods to improve the equity, effectiveness, and implementation of high-quality cancer screening and care. Dr. Rendle is the PI of the Penn Telehealth Research Center of Excellence (P50CA271338), an innovative Center grant that seeks to integrate telehealth equitably across the cancer care continuum. Additionally, she is MPI of a large implementation trial in Botswana that seeks to improve timely treatment in women living with HIV and diagnosed with cervical cancer (U01CA275032). As a methodological expert in implementation science and mixed methods, she co-leads the Methods Core of the Penn Implementation Science Center for Cancer (1P50CA244690), an innovative project designed to improve implementation of evidence-based interventions in cancer care. She is also an appointed member of the NCI Board of Scientific Advisors.
Dr. Rendle earned her PhD in Anthropology and Social Work from the University of Michigan. She also earned her MPH in Epidemiology from the University of California, Berkeley, and completed her postdoctoral training at the National Cancer Institute’s Cancer Prevention Fellowship.
